132 related articles for article (PubMed ID: 2339563)
21. [Immunological characteristics of the side-effects of antibacterial preparations in pulmonary tuberculosis patients].
Samarash VS
Vrach Delo; 1986 Nov; (11):25-6. PubMed ID: 3825037
[No Abstract] [Full Text] [Related]
22. [Mumie as a pathogenetic agent in the treatment of tuberculosis].
Agzamov RA; Arifkhanova SI; Vakhidova GA
Probl Tuberk; 1988; (7):49-52. PubMed ID: 3265209
[No Abstract] [Full Text] [Related]
23. [Combined therapy of pulmonary tuberculosis by using recombinant interleukins].
Skvortsova LA; Pavlova MV; Vinogradova TI; Archakova LI
Probl Tuberk Bolezn Legk; 2003; (10):9-12. PubMed ID: 14669620
[TBL] [Abstract][Full Text] [Related]
24. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
[TBL] [Abstract][Full Text] [Related]
25. [Immunity parameters in children with prior intrathoracic tuberculosis].
Elufimova VF; Mitinskaia LA; Iukhimenko NV; Romanova RIu; Abramova ZP; Dem'ianenko NV; Baenskiĭ AV
Probl Tuberk; 2000; (2):23-5. PubMed ID: 10838903
[TBL] [Abstract][Full Text] [Related]
26. [Immunological shifts in pulmonary tuberculosis patients with tuberculin hyposensitization].
Morozov VL; Dzholdubaev YD; Toropova LA
Probl Tuberk; 1980 Jun; (6):15-8. PubMed ID: 7393903
[No Abstract] [Full Text] [Related]
27. [Specific immunity of patients with newly detected tuberculosis during chemotherapy].
Evdokimov VN
Probl Tuberk; 1984 Sep; (9):33-8. PubMed ID: 6334298
[No Abstract] [Full Text] [Related]
28. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
Erokhin VV
Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
[TBL] [Abstract][Full Text] [Related]
29. [Immunological indices of tuberculosis patients detected during a visit to a physician and during prophylactic examinations].
Rakhmetov BR
Probl Tuberk; 1979 Oct; (10):41-4. PubMed ID: 504108
[No Abstract] [Full Text] [Related]
30. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic.
Toyoara M
Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():288-91. PubMed ID: 4468026
[No Abstract] [Full Text] [Related]
31. [Changes in the immunological reactivity of guinea pigs experimentally infected with trichinelliasis after combined treatment with mebendazole and prednisolone].
Raisov TK; Temirbekov DA; Sadykov KB; Ozeretskovskaia NN
Med Parazitol (Mosk); 1988; (2):30-4. PubMed ID: 3412240
[No Abstract] [Full Text] [Related]
32. [Effect of use of bone marrow cells in therapy for experimental tuberculosis].
Pospelov LE; Isaev AA; Bocharova IV; Avdienko VG; Babaian SS; Pospelov AL; Guseva AN; Gergert VIa
Probl Tuberk Bolezn Legk; 2006; (10):60-3. PubMed ID: 17139835
[TBL] [Abstract][Full Text] [Related]
33. [Dynamics of bacterial populations in experimental destructive pulmonary tuberculosis under treatment].
Golişevskaia V
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):111-4. PubMed ID: 6264575
[TBL] [Abstract][Full Text] [Related]
34. [Morphological features of tissue reactions in combined treatment of experimental tuberculosis induced by xenobiotics].
Pavlov VA; Kazak TI; Kleĭn AV; Nosova NA
Probl Tuberk; 1995; (6):32-5. PubMed ID: 8524767
[TBL] [Abstract][Full Text] [Related]
35. [Effect of antitubercular chemotherapy on immune status within the first 3 months of the start of short-term treatment].
Cioflec D; Ion N; Tudorache V; Hudiţeanu O; Luţă V; Chira Z; Neagoe D; Stoienescu D; Jemna I; Sfetcu V
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(2):137-44. PubMed ID: 2849189
[No Abstract] [Full Text] [Related]
36. [Effect of chemotherapy combined with the use of tissue preparations on nonspecific immunity in patients with pulmonary tuberculosis].
Nersesian ON; Bogatyreva EV
Probl Tuberk; 1990; (1):28-31. PubMed ID: 2336432
[TBL] [Abstract][Full Text] [Related]
37. [Effect of experimental use of antitubercular preparations and various pathogenetic drugs on the immunological reactions of the body].
Beliakova OI; Kharakter ZhZ; Sibirnaia RI; Snitinskaia OS
Probl Tuberk; 1988; (4):65-8. PubMed ID: 3262223
[No Abstract] [Full Text] [Related]
38. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
[TBL] [Abstract][Full Text] [Related]
39. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
40. [State of immunobiological reactivity of experimental animals to tuberculosis and exposure to coal tar].
Pavlov VA; Nosova NA
Probl Tuberk; 1995; (3):47-8. PubMed ID: 7617637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
